VIGIL NEUROSCIENCE INC. - COMMON STOCK
3.2500
14-November-24 11:35:41
15 minutes delayed
Stocks
-0.0900
-2.69%
Today's range
3.1500 - 3.3500
ISIN
N/A
Source
NASDAQ
-
Vigil Neuroscience Announces FDA Has Lifted the Partial Clinical Hold on VGL101
30 Mar 2023 06:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at Stifel 2023 CNS Days
22 Mar 2023 06:00:00 By Nasdaq GlobeNewswire
-
21 Mar 2023 06:00:00 By Nasdaq GlobeNewswire
-
02 Mar 2023 15:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 06:00:01 By Nasdaq GlobeNewswire
-
15 Dec 2022 15:01:00 By Nasdaq GlobeNewswire
-
14 Dec 2022 15:01:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Host ALSP KOL Event on December 6, 2022
28 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports Third Quarter 2022 Financial Results and Provides Business Update
10 Nov 2022 06:00:02 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at Upcoming Investor Conferences
07 Nov 2022 06:00:01 By Nasdaq GlobeNewswire
-
02 Nov 2022 06:00:01 By Nasdaq GlobeNewswire
-
01 Nov 2022 06:00:01 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at 2022 Morgan Stanley Global Healthcare Conference
01 Sep 2022 06:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Announces $75 Million Private Placement Financing
12 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports Second Quarter 2022 Financial Results and Provides Business Update
08 Aug 2022 06:00:01 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at 2022 Wedbush PacGrow Healthcare Virtual Conference
02 Aug 2022 06:00:01 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Strengthens Board of Directors with Appointment of Suzanne Bruhn, Ph.D.
28 Jul 2022 06:00:01 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Expands VGL101 Phase 1 Trial to Australia
07 Jun 2022 06:00:01 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at 2022 Jefferies Global Healthcare Conference
01 Jun 2022 06:00:01 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports First Quarter 2022 Financial Results and Provides Business Highlights
12 May 2022 06:00:01 By Nasdaq GlobeNewswire